203 related articles for article (PubMed ID: 34288927)
21. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Manly DA; Wang J; Glover SL; Kasthuri R; Liebman HA; Key NS; Mackman N
Thromb Res; 2010 Jun; 125(6):511-2. PubMed ID: 19854471
[TBL] [Abstract][Full Text] [Related]
22. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay.
Tripodi A; Branchi A; Chantarangkul V; Clerici M; Merati G; Artoni A; Mannucci PM
J Thromb Thrombolysis; 2011 Feb; 31(2):165-72. PubMed ID: 20640482
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine.
Yates KR; Welsh J; Echrish HH; Greenman J; Maraveyas A; Madden LA
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):680-7. PubMed ID: 21941170
[TBL] [Abstract][Full Text] [Related]
24. Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not.
Park MS; Owen BA; Ballinger BA; Sarr MG; Schiller HJ; Zietlow SP; Jenkins DH; Ereth MH; Owen WG; Heit JA
Surgery; 2012 Jun; 151(6):831-6. PubMed ID: 22316436
[TBL] [Abstract][Full Text] [Related]
25. Air pollution-associated procoagulant changes: the role of circulating microvesicles.
Emmerechts J; Jacobs L; Van Kerckhoven S; Loyen S; Mathieu C; Fierens F; Nemery B; Nawrot TS; Hoylaerts MF
J Thromb Haemost; 2012 Jan; 10(1):96-106. PubMed ID: 22066779
[TBL] [Abstract][Full Text] [Related]
26. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Wang M; Huang X; Zhu M; Zhang S; Zhang Y
Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
Muhsin-Sharafaldine MR; Kennedy BR; Saunderson SC; Buchanan CR; Dunn AC; Faed JM; McLellan AD
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):286-295. PubMed ID: 27864149
[TBL] [Abstract][Full Text] [Related]
28. Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?
Medeiros SK; Emery B; Bhagirath V; Parpia S; Dwivedi DJ; Dwivedi NJ; Kearon C; Liaw PC
Thromb Res; 2020 Feb; 186():13-19. PubMed ID: 31838139
[TBL] [Abstract][Full Text] [Related]
29. Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia.
Marchetti M; Tartari CJ; Russo L; Panova-Noeva M; Leuzzi A; Rambaldi A; Finazzi G; Woodhams B; Falanga A
Am J Hematol; 2014 Jan; 89(1):68-73. PubMed ID: 24009132
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
31. Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells.
Rousseau A; Larsen AK; Van Dreden P; Sabbah M; Elalamy I; Gerotziafas GT
Int J Oncol; 2017 Dec; 51(6):1747-1756. PubMed ID: 29075790
[TBL] [Abstract][Full Text] [Related]
32. Procoagulant role of neutrophil extracellular traps in patients with gastric cancer.
Yang C; Sun W; Cui W; Li X; Yao J; Jia X; Li C; Wu H; Hu Z; Zou X
Int J Clin Exp Pathol; 2015; 8(11):14075-86. PubMed ID: 26823721
[TBL] [Abstract][Full Text] [Related]
33. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism.
Bal L; Ederhy S; Di Angelantonio E; Toti F; Zobairi F; Dufaitre G; Meuleman C; Mallat Z; Boccara F; Tedgui A; Freyssinet JM; Cohen A
Arch Cardiovasc Dis; 2010; 103(6-7):394-403. PubMed ID: 20800803
[TBL] [Abstract][Full Text] [Related]
35. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays.
Noubouossie DC; Lê PQ; Rozen L; Debaugnies F; Ferster A; Demulder A
Thromb Res; 2012 Aug; 130(2):259-64. PubMed ID: 22079446
[TBL] [Abstract][Full Text] [Related]
37. Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation.
Mørk M; Andreasen JJ; Rasmussen LH; Lip GYH; Pedersen S; Bæk R; Jørgensen MM; Kristensen SR
Thromb Res; 2019 Jan; 173():141-150. PubMed ID: 30530119
[TBL] [Abstract][Full Text] [Related]
38. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events.
Campello E; Zabeo E; Radu CM; Spiezia L; Gavasso S; Fadin M; Woodhams B; Vettor R; Simioni P
Thromb Haemost; 2015 Jan; 113(1):85-96. PubMed ID: 25318550
[TBL] [Abstract][Full Text] [Related]
39. Coagulation activation in sickle cell trait: an exploratory study.
Amin C; Adam S; Mooberry MJ; Kutlar A; Kutlar F; Esserman D; Brittain JE; Ataga KI; Chang JY; Wolberg AS; Key NS
Br J Haematol; 2015 Nov; 171(4):638-46. PubMed ID: 26511074
[TBL] [Abstract][Full Text] [Related]
40. Cancer procoagulant in patients with adenocarcinomas.
Kaźmierczak M; Lewandowski K; Wojtukiewicz MZ; Turowiecka Z; Kołacz E; Lojko A; Skrzydlewska E; Zawilska K; Komarnicki M
Blood Coagul Fibrinolysis; 2005 Nov; 16(8):543-7. PubMed ID: 16269926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
